Strength transfer refers to the gain in strength in an untrained exercise resulting from training another exercise. This study aims to determine whether whole and selective hamstring hypertrophy influence the magnitude of strength transfer between the Nordic hamstring exercise (NHE) and the stiff-leg Deadlift (SDL). Using a blinded randomized controlled design, thirty-six resistance-untrained individuals were assigned either to a control group (CON), a NHE group, and a SDL group, the two resistance training programs being performed three times per week for nine weeks. Semimembranosus (SM), semitendinosus (ST), and biceps femoris (BF) hypertrophy was estimated from changes in the muscle volume. Strength transfer was measured by changes in the one-repetition maximum (1RM) of the non-trained exercise. After the resistance training programs, similar and significant whole hypertrophy was observed in both training groups (NHE: 11.4±6.5%, and SDL: 7.0±8.1%). The NHE group and SDL group, however, presented a selective hypertrophy of ST (24.3±10.8%) and SM (11.2±12.7%), respectively. Conversely, no difference in strength transfer was observed between the NHE group (10.7±8.5%) and the SDL group (20.7±15.0%) (p=0.06). Finally, non-significant correlations were found between strength transfer and both whole and selective hamstring hypertrophy (r≤0.3), except for the BF in SDL (r=0.6). We conclude that hamstring hypertrophy has a minimal role in strength transfer in resistance-untrained individuals. These findings suggest that, even in presence of hypertrophy, prevention and rehabilitation programs should include both Nordic hamstring and stiff-leg Deadlift exercises in the same training block to increase hamstring strength across both knee flexion-oriented and hip extension-oriented tasks.

The authors have declared no competing interest.

NCT06164249

Region Pays de la Loire for the grant etoiles Montantes conceded to Lilian LACOURPAILLE

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committed Paris IV gave ethical approval for this work 2021A0299338

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors